Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > TP53BP2(Gene name) > Human
  • Add your favorite
  • TP53BP2 (Gene name),
  • Apoptosis-stimulating of p53 protein 2 (Protein name ),  ASPP2_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    TP53BP2(ASPP2;BBP);
    Protein name:
    Apoptosis-stimulating of p53 protein 2;
    Alternative:
    Renal carcinoma antigen NY-REN-51;Bcl2-binding protein(Bbp);Tumor suppressor p53-binding protein 2(53BP2;p53-binding protein 2;p53BP2);
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Binds to the central domain of TP53 as well as to BCL2. Interacts with protein phosphatase 1. Interacts with RELA NF-kappa-B subunit. This interaction probably prevents the activation of apoptosis, possibly by preventing its interaction with TP53. Interacts with APC2 and APPBP1. Interacts with DDX42 (via the C-terminus); the interaction is not inhibited by TP53BP2 ubiquitination and is independent of p53/TP53.
    Function:
    Regulator that plays a central role in regulation of apoptosis and cell growth via its interactions. Regulates TP53 by enhancing the DNA binding and transactivation function of TP53 on the promoters of proapoptotic genes in vivo. Inhibits the ability of APPBP1 to conjugate NEDD8 to CUL1, and thereby decreases APPBP1 ability to induce apoptosis. Impedes cell cycle progression at G2/M. Its apoptosis-stimulating activity is inhibited by its interaction with DDX42.
    Subcellular Location:
    Cytoplasm perinuclear region Nucleus Predominantly found in the perinuclear region. Some small fraction is nuclear. Sequester in the cytoplasm on overexpression of DDX42.
    Protein Attributes:
    Sequence length:
    1128
    Sequence:
    50:
    MMPMFLTVYL | SNNEQHFTEV | PVTPETICRD | VVDLCKEPGE | SDCHLAEVWC | 
    100:
    GSERPVADNE | RMFDVLQRFG | SQRNEVRFFL | RHERPPGRDI | VSGPRSQDPS | 
    150:
    LKRNGVKVPG | EYRRKENGVN | SPRMDLTLAE | LQEMASRQQQ | QIEAQQQLLA | 
    200:
    TKEQRLKFLK | QQDQRQQQQV | AEQEKLKRLK | EIAENQEAKL | KKVRALKGHV | 
    250:
    EQKRLSNGKL | VEEIEQMNNL | FQQKQRELVL | AVSKVEELTR | QLEMLKNGRI | 
    300:
    DSHHDNQSAV | AELDRLYKEL | QLRNKLNQEQ | NAKLQQQREC | LNKRNSEVAV | 
    350:
    MDKRVNELRD | RLWKKKAALQ | QKENLPVSSD | GNLPQQAASA | PSRVAAVGPY | 
    400:
    IQSSTMPRMP | SRPELLVKPA | LPDGSLVIQA | SEGPMKIQTL | PNMRSGAASQ | 
    450:
    TKGSKIHPVG | PDWSPSNADL | FPSQGSASVP | QSTGNALDQV | DDGEVPLREK | 
    500:
    EKKVRPFSMF | DAVDQSNAPP | SFGTLRKNQS | SEDILRDAQV | ANKNVAKVPP | 
    550:
    PVPTKPKQIN | LPYFGQTNQP | PSDIKPDGSS | QQLSTVVPSM | GTKPKPAGQQ | 
    600:
    PRVLLSPSIP | SVGQDQTLSP | GSKQESPPAA | AVRPFTPQPS | KDTLLPPFRK | 
    650:
    PQTVAASSIY | SMYTQQQAPG | KNFQQAVQSA | LTKTHTRGPH | FSSVYGKPVI | 
    700:
    AAAQNQQQHP | ENIYSNSQGK | PGSPEPETEP | VSSVQENHEN | ERIPRPLSPT | 
    750:
    KLLPFLSNPY | RNQSDADLEA | LRKKLSNAPR | PLKKRSSITE | PEGPNGPNIQ | 
    800:
    KLLYQRTTIA | AMETISVPSY | PSKSASVTAS | SESPVEIQNP | YLHVEPEKEV | 
    850:
    VSLVPESLSP | EDVGNASTEN | SDMPAPSPGL | DYEPEGVPDN | SPNLQNNPEE | 
    900:
    PNPEAPHVLD | VYLEEYPPYP | PPPYPSGEPE | GPGEDSVSMR | PPEITGQVSL | 
    950:
    PPGKRTNLRK | TGSERIAHGM | RVKFNPLALL | LDSSLEGEFD | LVQRIIYEVD | 
    1000:
    DPSLPNDEGI | TALHNAVCAG | HTEIVKFLVQ | FGVNVNAADS | DGWTPLHCAA | 
    1050:
    SCNNVQVCKF | LVESGAAVFA | MTYSDMQTAA | DKCEEMEEGY | TQCSQFLYGV | 
    1100:
    QEKMGIMNKG | VIYALWDYEP | QNDDELPMKE | GDCMTIIHRE | DEDEIEWWWA | 
    1128:
    RLNDKEGYVP | RNLLGLYPRI | KPRQRSLA
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    MIM:
    String:
    Pfam:
    SMR:
    UniGene:
    KEGG:
    Uniprot:
     
    FOR
    ELISA Kit for Human Apoptosis-stimulating of p53 protein 2
    ELISA Kit for Human Apoptosis-stimulating of p53 protein 2
    CLIA Kit for Human Apoptosis-stimulating of p53 protein 2
    CLIA Kit for Human Apoptosis-stimulating of p53 protein 2
    Polyclonal Antibody for Human Apoptosis-stimulating of p53 protein 2
    Polyclonal Antibody for Human Apoptosis-stimulating of p53 protein 2
    Monoclonal Antibody for Human Apoptosis-stimulating of p53 protein 2
    Monoclonal Antibody for Human Apoptosis-stimulating of p53 protein 2
    Protein for Human Apoptosis-stimulating of p53 protein 2
    Protein for Human Apoptosis-stimulating of p53 protein 2

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "The p53-binding protein 53BP2 also interacts with Bcl2 and impedes cell cycle progression at G2/M."
      Naumovski L. , Cleary M.L.
      Mol. Cell. Biol.16:3884-3892(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2);INTERACTION WITH BCL2
    2. 2.
      "ASPP proteins specifically stimulate the apoptotic function of p53."
      Samuels-Lev Y. , O'Connor D.J. , Bergamaschi D. , Trigiante G. , Hsieh J.-K. , Zhong S. , Campargue I. , Naumovski L. , Crook T. , Lu X.
      Mol. Cell8:781-794(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);FUNCTION;TISSUE SPECIFICITY;INTERACTION WITH TP53
    3. 3.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)
      tissue: Amygdala.
    4. 4.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    5. 5.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
      tissue: Testis.
      tissue: Uterus.
    6. 6.
      "Two cellular proteins that bind to wild-type but not mutant p53."
      Iwabuchi K. , Bartel P.L. , Li B. , Marraccino R. , Fields S.
      Proc. Natl. Acad. Sci. U.S.A.91:6098-6102(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 600-1128;INTERACTION WITH TP53
    7. 7.
      "Antigens recognized by autologous antibody in patients with renal-cell carcinoma."
      Scanlan M.J. , Gordan J.D. , Williamson B. , Stockert E. , Bander N.H. , Jongeneel C.V. , Gure A.O. , Jaeger D. , Jaeger E. , Knuth A. , Chen Y.-T. , Old L.J.
      Int. J. Cancer83:456-464(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION AS A RENAL CANCER ANTIGEN
      tissue: Renal cell carcinoma.
    8. 8.
      "NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2."
      Yang J.-P. , Hori M. , Takahashi N. , Kawabe T. , Kato H. , Okamoto T.
      Oncogene18:5177-5186(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: TISSUE SPECIFICITY;INTERACTION WITH RELA
    9. 9.
      "APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus."
      Nakagawa H. , Koyama K. , Murata Y. , Morito M. , Akiyama T. , Nakamura Y.
      Cancer Res.60:101-105(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH APC2;MUTAGENESIS OF TRP-1098;SUBCELLULAR LOCATION
    10. 10.
      "Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53."
      Lopez C.D. , Ao Y. , Rohde L.H. , Perez T.D. , O'Connor D.J. , Lu X. , Ford J.M. , Naumovski L.
      Mol. Cell. Biol.20:8018-8025(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INDUCTION
    11. 11.
      "Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines."
      Mori T. , Okamoto H. , Takahashi N. , Ueda R. , Okamoto T.
      FEBS Lett.465:124-128(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: TISSUE SPECIFICITY
    12. 12.
      "ASPP2 inhibits APP-BP1-mediated NEDD8 conjugation to cullin-1 and decreases APP-BP1-induced cell proliferation and neuronal apoptosis."
      Chen Y. , Liu W. , Naumovski L. , Neve R.L.
      J. Neurochem.85:801-809(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;INTERACTION WITH APPBP1
    13. 13.
      "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry."
      Brill L.M. , Salomon A.R. , Ficarro S.B. , Mukherji M. , Stettler-Gill M. , Peters E.C.
      Anal. Chem.76:2763-2772(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    14. 14.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480 AND SER-556;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    15. 15.
      "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
      Gauci S. , Helbig A.O. , Slijper M. , Krijgsveld J. , Heck A.J. , Mohammed S.
      Anal. Chem.81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    16. 16.
      "The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis."
      Uhlmann-Schiffler H. , Kiermayer S. , Stahl H.
      Oncogene28:2065-2073(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;INTERACTION WITH DDX42;SUBCELLULAR LOCATION
    17. 17.
      "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
      Mayya V. , Lundgren D.H. , Hwang S.-I. , Rezaul K. , Wu L. , Eng J.K. , Rodionov V. , Han D.K.
      Sci. Signal.2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    18. 18.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480; SER-556 AND SER-572;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    19. 19.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    20. 20.
      "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
      Rigbolt K.T. , Prokhorova T.A. , Akimov V. , Henningsen J. , Johansen P.T. , Kratchmarova I. , Kassem M. , Mann M. , Olsen J.V. , Blagoev B.
      Sci. Signal.4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    21. 21.
      "Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2."
      Gorina S. , Pavletich N.P.
      Science274:1001-1005(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 892-1128
    22. 22.
      "Solution structure of ASPP2 N-terminal domain (N-ASPP2) reveals a ubiquitin-like fold."
      Tidow H. , Andreeva A. , Rutherford T.J. , Fersht A.R.
      J. Mol. Biol.371:948-958(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 1-83
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2026 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter